Medicare Enrolled

Dr. William Naguszewski, M.D.

Neurology · Rome, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
126 THREE RIVERS DR NE, Rome, GA 30161
7062950070
Registered in NPPES since 2005
NPI: 1134103997 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Naguszewski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naguszewski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Naguszewski

Dr. William Naguszewski is a neurology specialist in Rome, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Naguszewski performed 8,413 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Naguszewski received a total of $16,780 from 84 pharmaceutical and/or device companies across 897 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Naguszewski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 12% volume in GA $16,780 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
8,413
Medicare services
Top 12% in GA for neurology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
7,200 $5 $7
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
494 $82 $134
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
278 $55 $95
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
84 $103 $181
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
77 $125 $184
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
56 $150 $333
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
45 $44 $103
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
41 $193 $465
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
33 $94 $154
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
24 $73 $130
New patient office visit, complex (60-74 min) 23 $127 $234
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
18 $174 $282
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
16 $75 $122
Home sleep test with portable monitor
An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels.
13 $35 $112
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $321 $524
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,780
Total received (2018-2024)
Avg $2,397/year across 7 years
Top 18% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
897
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,716
2023
$3,356
2022
$3,060
2021
$2,790
2020
$1,335
2019
$1,109
2018
$1,414

Payments by company (2024)

ABBVIE INC.
$500
JAZZ PHARMACEUTICALS INC.
$336
PFIZER INC.
$298
HARMONY BIOSCIENCES LLC
$251
MDD US Operations, LLC
$229
Biogen, Inc.
$209
UCB, Inc.
$162
TG Therapeutics, Inc.
$139
Harmony Biosciences Llc
$134
Avadel CNS Pharmaceuticals, LLC
$118
Eisai Inc.
$111
Novartis Pharmaceuticals Corporation
$106
ARGENX US, INC.
$99
Lilly USA, LLC
$82
Amneal Pharmaceuticals LLC
$80
Neurelis, Inc.
$67
CATALYST PHARMACEUTICALS, INC.
$66
Neurocrine Biosciences, Inc.
$60
Otsuka America Pharmaceutical, Inc.
$58
Lundbeck LLC
$55
Kyowa Kirin, Inc.
$53
Sumitomo Pharma America, Inc.
$52
SK Life Science, Inc.
$46
ANI Pharmaceuticals, Inc.
$46
Vanda Pharmaceuticals Inc.
$42
Alexion Pharmaceuticals, Inc.
$41
Amgen Inc.
$39
Teva Pharmaceuticals USA, Inc.
$36
Genentech USA, Inc.
$34
CSL Behring
$29
Xeris Pharmaceuticals, Inc.
$22
Axsome Therapeutics, Inc.
$22
Inspire Medical Systems, Inc.
$21
AstraZeneca Pharmaceuticals LP
$20
ACADIA Pharmaceuticals Inc
$20
Octapharma USA, Inc.
$18
Resmed Corp
$15
Top 3 companies account for 30.5% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,486
ABBVIE INC.
$1,192
Supernus Pharmaceuticals, Inc.
$913
Teva Pharmaceuticals USA, Inc.
$872
UCB, Inc.
$867
Harmony Biosciences LLC
$617
LivaNova USA, Inc.
$602
JAZZ PHARMACEUTICALS INC.
$579
PFIZER INC.
$543
Novartis Pharmaceuticals Corporation
$438
HARMONY BIOSCIENCES LLC
$384
Amneal Pharmaceuticals LLC
$363
Lilly USA, LLC
$342
AbbVie Inc.
$316
MDD US Operations, LLC
$308
Eisai Inc.
$307
Lundbeck LLC
$284
Neurelis, Inc.
$284
Amgen Inc.
$263
IMPEL PHARMACEUTICALS INC.
$257
Avanir Pharmaceuticals, Inc.
$257
Biohaven Pharmaceutical Holding Company Ltd.
$253
ARGENX US, INC.
$237
SK Life Science, Inc.
$214
Neurocrine Biosciences, Inc.
$212
Genentech USA, Inc.
$196
ACADIA Pharmaceuticals Inc
$196
UPSHER-SMITH LABORATORIES LLC
$192
Kyowa Kirin, Inc.
$191
Alexion Pharmaceuticals, Inc.
$188
Jazz Pharmaceuticals Inc.
$181
Allergan Inc.
$174
Alnylam Pharmaceuticals Inc.
$157
Sunovion Pharmaceuticals Inc.
$154
TG Therapeutics, Inc.
$139
Otsuka America Pharmaceutical, Inc.
$138
Allergan, Inc.
$135
Harmony Biosciences Llc
$134
CSL Behring
$125
Boston Scientific Corporation
$122
Avadel CNS Pharmaceuticals, LLC
$118
Greenwich Biosciences, Inc.
$110
Mallinckrodt Hospital Products Inc.
$106
Janssen Pharmaceuticals, Inc
$92
Axsome Therapeutics, Inc.
$92
Avion Pharmaceuticals
$91
Acorda Therapeutics, Inc
$85
BANNER LIFE SCIENCES, LLC
$78
Upsher-Smith Laboratories LLC
$75
CATALYST PHARMACEUTICALS, INC.
$66
Xeris Pharmaceuticals, Inc.
$63
IDORSIA PHARMACEUTICALS US INC
$62
Vanda Pharmaceuticals Inc.
$59
EISAI INC.
$55
Corium, LLC
$53
Biohaven Pharmaceuticals, Inc.
$53
Sumitomo Pharma America, Inc.
$52
ANI Pharmaceuticals, Inc.
$46
AstraZeneca Pharmaceuticals LP
$43
TG THERAPEUTICS, INC.
$42
GENZYME CORPORATION
$40
Bausch Health US, LLC
$39
EMD Serono, Inc.
$38
Octapharma USA, Inc.
$35
Merz Pharmaceuticals, LLC
$31
Resmed Corp
$30
Otsuka Pharmaceutical Development & Commercialization, Inc.
$25
Impax Laboratories, Inc.
$23
Inspire Medical Systems, Inc.
$21
Catalyst Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$20
Horizon Therapeutics plc
$19
Adamas Pharmaceuticals, Inc.
$19
Marinus Pharmaceuticals, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
AQUESTIVE THERAPEUTICS, INC.
$16
Banner Life Sciences, LLC
$16
Arbor Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme Corporation
$15
Scilex Pharmaceuticals Inc.
$15
Strongbridge US INC.
$13
OWP Pharmaceuticals, Inc.
$13
US WorldMeds, LLC
$12
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AIRSENSE · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · CREXONT · DUOPA · Dayvigo · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FYCOMPA · Fycompa · GILENYA · GOCOVRI · GVOKE PFS · General - Pain Management · Gocovri · HETLIOZ · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · LINZESS · LUMRYZ · Lamotrigine Starter Kit · Leqembi · MAYZENT · MIGRANAL · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Sunosi · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZTALMY · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Rome?
Compare neurologists in the Rome area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
7
County median income
$62,540
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH REDMOND
8.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Naguszewski is a mixed practice specialist, with above-average Medicare volume (top 12% in GA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Naguszewski experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Naguszewski performed 7,200 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Naguszewski receive payments from pharmaceutical companies?
Yes. Dr. Naguszewski received a total of $16,780 from 84 companies across 897 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naguszewski's costs compare to other neurologists in Rome?
Dr. Naguszewski's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naguszewski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →